Repligen - RG-1068's Unit Acquisition

Repligen - RG-1068 raised a round of funding on January 06, 2015. Investors include Innovate Biopharmaceuticals.

Repligen (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. The company'…

Articles about Repligen - RG-1068's Unit Acquisition: